mail2

Spectrum Library

A Single Amino Acid Substitution Prevents Recognition of a Dominant Human Aquaporin-4 Determinant in the Context of HLA-DRB1*03:01 by a Murine TCR

Publication Date April 2016

Quantitative Susceptibility Mapping Indicates a Disturbed Brain Iron Homeostasis in Neuromyelitis Optica – A Pilot Study.

Publication Date May 2016

Autoimmune AQP4 channelopathies and neuromyelitis optica spectrum disorders.

Publication Date March 2016

Evaluation of the 2015 diagnostic criteria for neuromyelitis optica spectrum disorder.

Publication Date April 2016

Rituximab monitoring and redosing in pediatric neuromyelitis optica spectrum disorder.

Publication Date January 2016

An update on the evidence for the efficacy and safety of rituximab in the management of neuromyelitis optica.

Publication Date March 2016

Subclinical primary retinal pathology in neuromyelitis optica spectrum disorder.

Publication Date May 2016

Normal volumes and microstructural integrity of deep gray matter structures in AQP4+ NMOSD.

Publication Date April 2016

Clobetasol promotes remyelination in a mouse model of neuromyelitis optica

Multiple sclerosis and neuromyelitis optica spectrum disorders: some similarities in two distinct diseases

Publication Date March 2016

Neuromyelitis optica spectrum disorders: Comparison according to the phenotype and serostatus.

Publication Date April 2016

Clinical utility of testing AQP4-IgG in CSF: Guidance for physicians.

Publication Date April 2016

Launch Dashboard

Dashboard

Fast Facts about NMOSD

NMOSD Symptoms Treatment Relapse Diagnosis Doctors Research News Advocate Helpline Resilience Events